menu
    • menu

    Company profile for Burning Rock Dx

    NEW Drugs in Dev: 2
    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Founded in March 2014, Burning Stone has built more than 10,000 square meters of inspection, R&D and GMP workshops in Beijing, Shanghai and Guangzhou. Burning Stone Medicine focuses on individualized treatment guidance for cancer patients. It is based on second-generation sequencing and medical bioinformatics. The molecular pathology of conventional tumors is the cornerstone. It is committed to creating a one-stop solution for...
    Founded in March 2014, Burning Stone has built more than 10,000 square meters of inspection, R&D and GMP workshops in Beijing, Shanghai and Guangzhou. Burning Stone Medicine focuses on individualized treatment guidance for cancer patients. It is based on second-generation sequencing and medical bioinformatics. The molecular pathology of conventional tumors is the cornerstone. It is committed to creating a one-stop solution for individualized treatment of tumors and clinical research services. Burning Stone has an efficient and professional bioinformatics analysis and R&D team, as well as an industry-leading team in operations management.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Burning Rock DxChina Flag
    Country
    Country
    China
    Address
    Address
    Building, No. 18, No. 39, East Third Ring Road, Chaoyang District, Beijing, 20...
    Telephone
    Telephone
    400-689-7600
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.brbiotech.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/burning-rock-biotech
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Burning Rock Announces Founder's Purchase Of Its ADSs
    Burning Rock Announces Founder's Purchase Of Its ADSs

    05 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/05/3212422/0/en/Burning-Rock-Announces-Founder-s-Purchase-of-Its-ADSs.html

    GLOBENEWSWIRE
    05 Jan 2026
    Share Share
    Burning Rock Sets 2025 Annual Meeting For December 23, 2025
    Burning Rock Sets 2025 Annual Meeting For December 23, 2025

    01 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/01/3196740/0/en/Burning-Rock-Announces-2025-Annual-General-Meeting-to-be-Held-on-December-23-2025.html

    GLOBENEWSWIRE
    01 Dec 2025
    Share Share
    Burning Rock Reports Third Quarter 2025 Financial Results
    Burning Rock Reports Third Quarter 2025 Financial Results

    20 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/20/3191590/0/en/Burning-Rock-Reports-Third-Quarter-2025-Financial-Results.html

    GLOBENEWSWIRE
    20 Nov 2025
    Share Share
    Burning Rock's Oncoguide Oncoscreen Plus CDX Approved In Japan
    Burning Rock's Oncoguide Oncoscreen Plus CDX Approved In Japan

    24 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/24/3155203/0/en/Burning-Rock-s-OncoGuide-OncoScreen-Plus-CDx-System-Now-Approved-in-Japan-as-a-Companion-Diagnostic-for-Capivasertib-in-Breast-Cancer.html

    GLOBENEWSWIRE
    24 Sep 2025
    Share Share
    Burning Rock's Q2 2025 Financial Results Released
    Burning Rock's Q2 2025 Financial Results Released

    08 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/08/3145799/0/en/Burning-Rock-Reports-Second-Quarter-2025-Financial-Results.html

    GLOBENEWSWIRE
    08 Sep 2025
    Share Share
    Burning Rock Reports First Quarter 2025 Financial Results
    Burning Rock Reports First Quarter 2025 Financial Results

    06 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/06/3094905/0/en/Burning-Rock-Reports-First-Quarter-2025-Financial-Results.html

    GLOBENEWSWIRE
    06 Jun 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search